TXG logo

10x Genomics (TXG) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

12 September 2019

Indexes:

Not included

Description:

10x Genomics, Inc. is an American biotechnology company that develops and manufactures gene sequencing technology used in scientific research. Registered in 2012 in the state of Delaware. The company offers tools, consumables, and software for analyzing biological systems at a resolution and scale that allows for analysis at the cellular level. Integrated solutions are used by biotechnology companies specializing in fundamental research in the fields of biology and medicine, including oncology, immunology, and neurobiology.

Events Calendar

Earnings

Next earnings date:

Feb 14, 2025

Recent quarterly earnings:

Oct 29, 2024

Recent annual earnings:

Feb 15, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

July 17, 2006

Analyst ratings

Recent major analysts updates

01 Nov '24 Barclays
Overweight
30 Oct '24 UBS
Neutral
30 Oct '24 JP Morgan
Neutral
30 Oct '24 Goldman Sachs
Sell
30 Oct '24 Citigroup
Buy
15 Oct '24 Barclays
Overweight
10 Oct '24 Stephens & Co.
Overweight
10 Oct '24 Canaccord Genuity
Buy
04 Sept '24 Stephens & Co.
Overweight
03 Sept '24 Leerink Partners
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Torex Gold to Restart Operations and Project Activities at the Morelos Complex
Torex Gold to Restart Operations and Project Activities at the Morelos Complex
Torex Gold to Restart Operations and Project Activities at the Morelos Complex
TXG
newsfilecorp.com17 December 2024

Toronto, Ontario--(Newsfile Corp. - December 17, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) reports that the Director General of Mines under the Federal Ministry of Economy has lifted the temporary suspension notice and allowed for all activities within the Morelos Complex to resume. Jody Kuzenko, President & CEO of Torex, stated: "Following notification that the temporary suspension has been lifted by the Director General of Mines, all production and development activities at the Morelos Complex will resume, including open pit and underground mining, processing operations, and all activities associated with the Media Luna Project.

Torex Gold Receives Notice of Temporary Suspension from the Ministry of Economy
Torex Gold Receives Notice of Temporary Suspension from the Ministry of Economy
Torex Gold Receives Notice of Temporary Suspension from the Ministry of Economy
TXG
newsfilecorp.com09 December 2024

Toronto, Ontario--(Newsfile Corp. - December 9, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) reports that the Company has received a notification from the Director General of Mines under the Federal Ministry of Economy that all activities within the Morelos Property are to be temporarily suspended to support their inspection associated with the fatal incident at the El Limón Guajes underground mine ("ELG Underground") on December 5th. As a result, all operational and project activities within the Morelos Complex have been temporarily halted pending permission from officials to resume activities.

Torex Gold Provides an Update on the Fatalities at ELG Underground
Torex Gold Provides an Update on the Fatalities at ELG Underground
Torex Gold Provides an Update on the Fatalities at ELG Underground
TXG
newsfilecorp.com09 December 2024

Toronto, Ontario--(Newsfile Corp. - December 9, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) provides an update on the carbon monoxide exposure at the El Limón Guajes underground mine ("ELG Underground") that claimed the lives of two employees and one contractor and injured a second contractor. The relevant authorities have all been notified and the Company is fully cooperating with regulators.

Torex Gold Reports Three Fatalities at the ELG Underground Mine
Torex Gold Reports Three Fatalities at the ELG Underground Mine
Torex Gold Reports Three Fatalities at the ELG Underground Mine
TXG
newsfilecorp.com05 December 2024

Toronto, Ontario--(Newsfile Corp. - December 5, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) regretfully announces that during the day shift on December 5th, a fatal carbon monoxide gas exposure occurred, which claimed the lives of two employees and one contractor at the El Limón Guajes underground mine ("ELG Underground"). A fourth contract employee was also in the area and is currently in hospital and expected to recover.

Torex Gold Reports Compelling New Results from the 2024 ELG Underground Drilling Program
Torex Gold Reports Compelling New Results from the 2024 ELG Underground Drilling Program
Torex Gold Reports Compelling New Results from the 2024 ELG Underground Drilling Program
TXG
newsfilecorp.com02 December 2024

Results continue to indicate impressive grades and ongoing potential to expand resources and replace mined reserves (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - December 2, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) announces further assay results from the Company's 2024 drilling program at ELG Underground. The results to date support the Company's target of extending the mine life of ELG Underground by identifying new zones of higher-grade mineralization, expanding resources, and replacing and growing reserves.

Torex Gold Receives Approval for Normal Course Issuer Bid
Torex Gold Receives Approval for Normal Course Issuer Bid
Torex Gold Receives Approval for Normal Course Issuer Bid
TXG
newsfilecorp.com19 November 2024

Toronto, Ontario--(Newsfile Corp. - November 19, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) announces that it has received approval from the Toronto Stock Exchange (the "TSX") of its notice of intention to make a normal course issuer bid (the "NCIB"). Under the NCIB, Torex is authorized to purchase up to 7,116,777 of its common shares ("Common Shares"), representing approximately 10% of the public float as of November 13, 2024, during the period commencing on November 21, 2024 and ending on November 20, 2025.

Torex Gold Reports Results From The Ongoing 2024 EPO Exploration Program
Torex Gold Reports Results From The Ongoing 2024 EPO Exploration Program
Torex Gold Reports Results From The Ongoing 2024 EPO Exploration Program
TXG
newsfilecorp.com13 November 2024

Results indicate strong potential to upgrade Inferred Resources to Indicated Resources and expand resources to the north of the deposit (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - November 13, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) announces assay results from the Company's ongoing drilling program at EPO. The results to date support Torex's goal of expanding resources to the north of the deposit and upgrading Inferred Resources to Indicated Resources.

Torex Gold Reports Q3 2024 Results
Torex Gold Reports Q3 2024 Results
Torex Gold Reports Q3 2024 Results
TXG
newsfilecorp.com06 November 2024

Solid financial performance and robust cash generation driven by an all-in sustaining costs margin of 52% (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - November 6, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) reports the Company's financial and operational results for the three and nine months ended September 30, 2024. Torex will host a conference call tomorrow morning at 9:00 AM (ET) to discuss the results.

Torex Gold Provides Q3 2024 Update on Media Luna Project and Increases 2024 Production Guidance
Torex Gold Provides Q3 2024 Update on Media Luna Project and Increases 2024 Production Guidance
Torex Gold Provides Q3 2024 Update on Media Luna Project and Increases 2024 Production Guidance
TXG
newsfilecorp.com30 October 2024

Project 87% complete; plant tie-in schedule moves to February; first copper concentrate expected in Q1 (All amounts expressed in U.S. dollars unless otherwise stated) Toronto, Ontario--(Newsfile Corp. - October 30, 2024) - Torex Gold Resources Inc. (the "Company" or "Torex") (TSX: TXG) provides a Q3 2024 update on the development of its Media Luna Project ("Media Luna") and increases 2024 production guidance with a decision to undertake the tie-ins and upgrades to the processing plant in February 2025. Unless otherwise stated, progress and milestones referenced in this press release are as of September 30, 2024.

These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results
These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results
These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results
TXG
benzinga.com30 October 2024

10x Genomics, Inc. TXG reported a loss for the third quarter on Tuesday.

FAQ

  • What is the primary business of 10x Genomics?
  • What is the ticker symbol for 10x Genomics?
  • Does 10x Genomics pay dividends?
  • What sector is 10x Genomics in?
  • What industry is 10x Genomics in?
  • What country is 10x Genomics based in?
  • When did 10x Genomics go public?
  • Is 10x Genomics in the S&P 500?
  • Is 10x Genomics in the NASDAQ 100?
  • Is 10x Genomics in the Dow Jones?
  • When was 10x Genomics's last earnings report?
  • When does 10x Genomics report earnings?
  • Should I buy 10x Genomics stock now?

What is the primary business of 10x Genomics?

10x Genomics, Inc. is an American biotechnology company that develops and manufactures gene sequencing technology used in scientific research. Registered in 2012 in the state of Delaware. The company offers tools, consumables, and software for analyzing biological systems at a resolution and scale that allows for analysis at the cellular level. Integrated solutions are used by biotechnology companies specializing in fundamental research in the fields of biology and medicine, including oncology, immunology, and neurobiology.

What is the ticker symbol for 10x Genomics?

The ticker symbol for 10x Genomics is NASDAQ:TXG

Does 10x Genomics pay dividends?

No, 10x Genomics does not pay dividends

What sector is 10x Genomics in?

10x Genomics is in the Healthcare sector

What industry is 10x Genomics in?

10x Genomics is in the Health Information Services industry

What country is 10x Genomics based in?

10x Genomics is headquartered in United States

When did 10x Genomics go public?

10x Genomics's initial public offering (IPO) was on 12 September 2019

Is 10x Genomics in the S&P 500?

No, 10x Genomics is not included in the S&P 500 index

Is 10x Genomics in the NASDAQ 100?

No, 10x Genomics is not included in the NASDAQ 100 index

Is 10x Genomics in the Dow Jones?

No, 10x Genomics is not included in the Dow Jones index

When was 10x Genomics's last earnings report?

10x Genomics's most recent earnings report was on 29 October 2024

When does 10x Genomics report earnings?

The next expected earnings date for 10x Genomics is 14 February 2025

Should I buy 10x Genomics stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions